Browse Category

Investing News 7 December 2025

Axon Stock (AXON) Today: Price, Forecasts and AI Policing Risks – December 7, 2025

Axon Stock (AXON) Today: Price, Forecasts and AI Policing Risks – December 7, 2025

Axon Enterprise (NASDAQ: AXON) has become one of the market’s most hotly debated growth stocks. After a spectacular multi‑year run, the maker of TASER devices, body cameras and public‑safety software has been hit by a sharp sell‑off in late 2025, just as it doubles down on artificial intelligence and emergency‑communications acquisitions. As of the latest trade on December 6, 2025,…
Hertz Stock (HTZ) on December 7, 2025: EV Hangover, Turnaround Hopes and Wall Street’s Latest Forecasts

Hertz Stock (HTZ) on December 7, 2025: EV Hangover, Turnaround Hopes and Wall Street’s Latest Forecasts

Published: December 7, 2025 Hertz Global Holdings (NASDAQ: HTZ) has become one of the more polarizing stocks in the transportation sector. After a costly electric-vehicle (EV) bet, a CEO change, and a bruising 2024, the company has finally posted its first quarterly profit in nearly two years – yet the stock still trades as if many investors remain unconvinced. As…
CMG Stock: Can Chipotle’s Holiday Freebies Turn a Brutal 2025 Into a 2026 Comeback?

CMG Stock: Can Chipotle’s Holiday Freebies Turn a Brutal 2025 Into a 2026 Comeback?

Published: December 7, 2025 Key Takeaways There are two “CMG” tickers in the wild: Chipotle Mexican Grill (NYSE: CMG) and Computer Modelling Group (TSX: CMG). This article focuses on Chipotle Mexican Grill. Where CMG Stock Stands Today As of the latest close, CMG trades around $33.94 per share, giving Chipotle a market cap of roughly $52.5 billion and a price‑to‑earnings…
TNXP Stock Today, 7 December 2025: Price, Latest News and 2026 Forecasts for Tonix Pharmaceuticals

TNXP Stock Today, 7 December 2025: Price, Latest News and 2026 Forecasts for Tonix Pharmaceuticals

Tonix Pharmaceuticals (NASDAQ: TNXP) has quietly turned into one of 2025’s wildest biotech stories: a tiny company that finally won U.S. FDA approval for a fibromyalgia drug after a 15‑year drought, launched it in the U.S., expanded the same molecule into major depressive disorder (MDD), and watched its stock price explode more than 10,000% over the last year. Tonix Pharmaceuticals…
Carvana Stock Soars on S&P 500 Inclusion: Fresh Highs, Analyst Targets and 2025–2026 Outlook (December 7, 2025)

Carvana Stock Soars on S&P 500 Inclusion: Fresh Highs, Analyst Targets and 2025–2026 Outlook (December 7, 2025)

Carvana Co. (NYSE: CVNA) has moved from near-collapse in 2022 to the brink of blue‑chip status in 2025. The online used‑car retailer is now set to join the S&P 500, capping a stunning turnaround that has sent Carvana stock up roughly 97% year-to-date and about 10,000% from its 2022 lows below $4. CoinCentral As of the latest session, Carvana shares…
Lowe’s (LOW) Stock Outlook for 2026: Can a Dividend King Win After the FBM Mega‑Deal and Forecast Cut?

Lowe’s (LOW) Stock Outlook for 2026: Can a Dividend King Win After the FBM Mega‑Deal and Forecast Cut?

As of 7 December 2025, Lowe’s Companies (NYSE: LOW) sits at around $248 per share, in the middle of its 52‑week range of roughly $206 to $281, with a market value near $139 billion. StockAnalysis Despite a powerful dividend record and a big strategic push into the professional contractor market, LOW stock has actually lagged the broader U.S. market in…
RCAT Stock Forecast for 2025–2026: Can Red Cat Holdings Turn the Drone Supercycle Into Lasting Gains?

RCAT Stock Forecast for 2025–2026: Can Red Cat Holdings Turn the Drone Supercycle Into Lasting Gains?

Red Cat Holdings (NASDAQ: RCAT) is back in the spotlight. The defense‑drone specialist has just reshuffled its leadership team, posted explosive revenue growth, drawn fresh institutional money—and still trades well below its 2025 highs. As of the close on Friday, December 5, 2025, RCAT stock finished at $8.02, giving Red Cat a market capitalization of roughly $957 million. The shares…
Walgreens Boots Alliance (WBA) Stock in December 2025: Buyout Price, Delisting, and What’s Left for Investors

Walgreens Boots Alliance (WBA) Stock in December 2025: Buyout Price, Delisting, and What’s Left for Investors

As of December 7, 2025, WBA stock is no longer a normal stock at all. Walgreens Boots Alliance has been taken private by Sycamore Partners, its shares have been delisted from Nasdaq, and the old “WBA” ticker is now basically a historical artifact. Walgreens Boots Alliance Yet WBA keeps popping up in headlines — from a December 3 data breach…
VOO Stock Today: Vanguard S&P 500 ETF Near Record Highs as Inflows Smash All‑Time Records (December 7, 2025)

VOO Stock Today: Vanguard S&P 500 ETF Near Record Highs as Inflows Smash All‑Time Records (December 7, 2025)

Updated December 7, 2025 The Vanguard S&P 500 ETF (ticker: VOO) is ending 2025 in a position most index funds can only daydream about. The fund is trading around $630 per share, close to its 52‑week high and sitting on record‑breaking inflows that have turned it into the largest ETF in the world. The Motley Fool At the same time,…
ServiceNow (NOW) Stock on December 7, 2025: Stock Split, Veza Deal and 2025 Outlook for the AI Workflow Leader

ServiceNow (NOW) Stock on December 7, 2025: Stock Split, Veza Deal and 2025 Outlook for the AI Workflow Leader

As of December 7, 2025, ServiceNow (NYSE: NOW) sits at the crossroads of three big storylines:a looming 5‑for‑1 stock split, a push deeper into identity security via the Veza acquisition, and an AI‑driven growth engine that is still humming even as investors worry about valuation and macro risk. Shares of ServiceNow trade around $854 per share, giving the company a…
CleanSpark (CLSK) Stock on December 7, 2025: Earnings Surge, $1.15B Notes Deal and AI Pivot – What Investors Need to Know

CleanSpark (CLSK) Stock on December 7, 2025: Earnings Surge, $1.15B Notes Deal and AI Pivot – What Investors Need to Know

CleanSpark (NASDAQ: CLSK) has quietly turned into one of the loudest volatility machines in U.S. small caps: a Bitcoin miner, an emerging AI infrastructure play, and a stock that can move nearly 10% in a day without breaking a sweat. As of the close on December 5, 2025, CLSK traded around $13.7 per share, down roughly 8–9% on the day…
StockX Stock in 2025: Price, Valuation, IPO Hopes and How Investors Can (Actually) Get Exposure

StockX Stock in 2025: Price, Valuation, IPO Hopes and How Investors Can (Actually) Get Exposure

As of December 7, 2025, sneakerheads, collectors and private‑market investors are all watching the same thing: “StockX stock”—even though the company still isn’t publicly listed on any exchange. StockX, the Detroit‑based marketplace that brands itself as the “stock market of things,” remains a private, venture‑backed company. But a growing ecosystem of pre‑IPO platforms, secondary brokers and data providers now publishes…
1 420 421 422 423 424 561

Stock Market Today

  • Transcat Q4 CY2025 Sales Surpass Estimates on Strong 25.6% Growth
    February 3, 2026, 6:10 PM EST. Transcat (NASDAQ:TRNS) reported Q4 CY2025 revenue of $83.86 million, beating analyst expectations by 4.1% and marking a 25.6% year-on-year increase. The measurement equipment distributor serving pharmaceutical and industrial sectors posted adjusted earnings per share (EPS) of $0.26, missing estimates by 17.5%. Adjusted EBITDA came in at $10.07 million, falling short by 6.6%. Despite operating margin slipping to 0.1% from 4.3% last year, Transcat's five-year annualized revenue growth stands at a strong 13.4%, outpacing industry peers. Analysts project an 8.5% revenue rise over the next year, indicating continued demand. CEO Lee D. Rudow highlighted steady organic growth in service revenues, underlying resilience in Transcat's diverse business portfolio.
Go toTop